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Abstract
Research on influenza vaccine uptake has focused largely on intrapersonal determinants
(perceived risk, past vaccine acceptance, perceived vaccine safety) and on physician
recommendation. We utilized a social ecological framework to examine influenza vaccine uptake
during the 2009 H1N1 pandemic. Surveying an adult population (n=2079) in January 2010 with
significant oversamples of African Americans and Hispanics, we found that 18.4% (95% CI 15.6–
21.5) had gotten the 2009 H1N1 vaccine. Variables at each level of the social ecological model
were significant predictors of uptake as well as of intent to get the vaccine. The intrapersonal level
explained 53%, the interpersonal explained 47%, the institutional level explained 34%, and the
policy and community levels each explained 8% of the variance associated with vaccine uptake.
The levels together explained 65% of the variance, suggesting that interventions targeting multiple
levels of the framework would be more effective than interventions aimed at a single level.
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Background
Contrary to most health behavior theories, which focus predominantly on attitudinal
variables at the intrapersonal level, the Social Ecological Model (SEM) (McLeroy, Bibeau,
Steckler, & Glanz, 1988), argues that individual behavior is shaped by factors at multiple
levels, including institutional, community, and policy levels in addition to intrapersonal and
interpersonal levels. Although this model is widely accepted, rarely do researchers have the
opportunity to examine the importance of each level in a single study of the analysis of a
health behavior decision. We had the opportunity to do this during a real health crisis with a
clearly defined behavioral outcome, i.e., getting vaccinated for H1N1 during the 2009
influenza pandemic in the United States (US). Limited vaccine became available in October
2009, and was recommended for target groups totaling about 160 million people (Centers
for Disease Control and Prevention, 2010c) based on recommendations of the Advisory
Committee on Immunization Practices (ACIP) (Centers for Disease Control and
Prevention’s Advisory Committee on Immunization Practices, 2009). As vaccine availability
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increased, the Centers for Disease Control and Prevention (CDC) encouraged everyone,
including those aged ≥65, to get vaccinated (Centers for Disease Control and Prevention,
2010a).
The Social Ecological Model as a framework for Influenza Vaccine
Acceptance
Research on the determinants of influenza vaccine uptake has focused largely on
intrapersonal determinants such as perceived risk, past vaccine acceptance, and beliefs about
vaccine safety, and on physician recommendation (Chapman & Coups, 1999; Cummings,
Jette, Brock, & Haefner, 1979; Eastwood, Durrheim, Jones, & Butler, 2010; Maurer, Harris,
Parker, & Lurie, 2009; Maurer, Uscher-Pines, & Harris, 2010c; Oliver & Berger, 1979;
Quinn, Thomas, & Kumar, 2008; Schwarzinger, Flicoteaux, Cortarenoda, Obadia, & Moatti,
2010; Seale et al., 2010). In this comprehensive study of the factors correlated with vaccine
uptake in the US, we utilize the SEM as an organizing framework (Figure 1) to explore the
determinants of 2009 H1N1 influenza vaccine uptake with data from the 2009 H1N1
pandemic. In the following sections, we will discuss each level in the SEM and describe the
evidence for determinants of vaccine uptake at that level.
Intrapersonal level
Attitudes and beliefs are the typical variables measured for the intrapersonal level of
influence. In the case of H1N1 vaccination, perceptions of susceptibility to the disease,
effectiveness of the behavior (getting the vaccine) in affording protection against the
disease, and barriers to vaccination are expected to impact vaccine uptake based on such
behavioral theories as the Health Belief Model (Rosenstock, 1990) and Protection
Motivation Theory (Maddux & Rogers, 1983). Beliefs about the safety of vaccines, if
negative, can act as a barrier (Chapman & Coups, 1999; Oliver & Berger, 1979), or, if
positive, can promote vaccination (Chapman & Coups, 1999; Cummings et al., 1979;
Maurer, Uscher-Pines, & Harris, 2010b; Oliver & Berger, 1979). Trust in the government is
another belief that impacts engagement in a government-recommended health behavior
(Blanchard et al., 2005; Quinn, Kumar, Freimuth, Kidwell, & Musa, 2009). One measure,
which is behavioral rather than attitudinal, but is nonetheless an intrapersonal variable
correlated with vaccination, is past vaccine uptake: those who get the seasonal flu vaccine
regularly are more likely to get a new vaccine. Regular or recent seasonal flu vaccine uptake
was correlated with not only H1N1 vaccine uptake and intention to accept the vaccine
during the 2009 pandemic in multiple studies in Australia, France, and the US (Eastwood et
al., 2010; Maurer et al., 2009; Quinn et al., 2009; Schwarzinger et al., 2010; Seale et al.,
2010; Setbon & Raude), but also in many studies examining the correlates of influenza
vaccine uptake in general (see (Chapman & Coups, 1999) and references therein).
Knowledge about the issue may be an important intrapersonal influence on behavior. In a
vaccine shortage, perceived membership in a priority group for vaccination could impact
uptake more than actual membership in a priority group (Brewer & Hallman, 2006). We
will test the relation between perception (an intrapersonal level variable) with actual
membership in a priority group (a policy level variable) and its impact on vaccine uptake
during the H1N1 pandemic.
Interpersonal level
In the SEM, the interpersonal level refers to social influence from friends and family and
norms within social networks (McLeroy et al., 1988). Interpersonal relationships have major
influences on health behaviors including consulting a healthcare provider and cancer
screening (Ashida, Wilkinson, & Koehly, 2010; Kinney, Bloor, Martin, & Sandler, 2005;
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Pasick et al., 2009). In the context of vaccine uptake, people who believe that family and
friends want them to be vaccinated are more likely to accept the vaccine (Cummings et al.,
1979; Nowalk, Zimmerman, Shen, Jewell, & Raymund, 2004; Oliver & Berger, 1979;
Zimmerman et al., 2003). Furthermore, as the number of people getting the vaccine in one’s
environment increases, representing the social norm, vaccine uptake increases (Chapman &
Coups, 1999).
Institutional level
Institutions include healthcare organizations, ranging from primary care physicians to health
centers, which provide information on influenza and vaccines. Multiple studies have shown
that physician recommendations increase vaccine acceptance (Cummings et al., 1979;
Eastwood et al., 2010; Madhavan, Borker, Fernandes, Amonkar, & Rosenbluth, 2003; Quinn
et al., 2009; Schwarzinger et al., 2010). This determinant assumes access to and contact with
a regular primary care provider, a resource that is inequitably distributed, based on race/
ethnicity, income, and education (Agency for Healthcare Quality and Research, 2008).
Community level
At the community level, multiple factors could impact vaccine uptake, including presence of
the disease in one’s community. The social context of risk perception is often ignored but is
probably important for an infectious disease where one may worry about infecting others as
well as getting sick themselves. The social amplification of risk framework (Kasperson,
1988) supports the importance of collective social dynamics in shaping risk perception; we
will test the impact of such community-level risk on vaccine uptake.
Policy level
Membership in a vaccine priority group is expected to foster vaccine uptake (Brewer &
Hallman, 2006). Access to health insurance, as determined by federal policies, could impact
vaccination rates: insurance coverage for immunization is a significant predictor of vaccine
uptake (Madhavan et al., 2003). It is sometimes argued that health insurance coverage is a
personal choice and should not be viewed as an issue of access. The uninsured are, however,
overwhelmingly also the poor, the low-wage-earners, and those without children, who do
not qualify under Medicaid’s stringent standards (Henry J. Kaiser Family Foundation,
2003). From this standpoint of the social determinants of health behaviors, we view health
insurance coverage as an issue of access in this study. Policies governing access to health
insurance often determine access to vaccine and are therefore important in vaccine decision
making. In the 2009 H1N1 pandemic, federal funding covered the costs of H1N1 vaccine
and its administration at public health departments, mass vaccination clinics, and through
commercial community vaccinators effectively removing the need for insurance (Centers for
Disease Control and Prevention, 2009) if people were willing to get vaccinated at these
venues. Thus, during the pandemic, we hypothesize that access to health insurance would
not have been a barrier to vaccination if people were aware of the free availability of vaccine
and willing to be vaccinated at selected locations.
In this study, we examine the significance of variables in each level of the SEM in
predicting H1N1 vaccine uptake by analyzing both behavior and behavioral intent during the
2009 H1N1 pandemic. We believe that given the cross-sectional nature of the study, a
comparison of attitudinal determinants impacting ‘having gotten the vaccine’ and ‘intent to
get the vaccine’ allows us to accurately conclude which variables are determinants of
vaccine uptake. We also examine the relationship between perceived and objective
membership in a priority group, and its effect on vaccine uptake; this could have important
implications for risk communication with people who are recommended to get the vaccine.
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A comprehensive understanding of the determinants of this primary preventive behavior
could inform the choice of interventions to improve vaccine coverage.
Methods
A representative sample of the US population was randomly drawn from the Knowledge
Networks (KN) online research panel, composed of approximately 50,000 people. KN uses
probability-based sampling methods and the dual sampling frames of random-digit dial
sampling and address-based probability sampling (utilizing the US Postal Service’s Delivery
Sequence File) to recruit people to the panel. Using both sample frames ensures that
households without telephones and cell-phone-only households, as well as households not
otherwise reachable by telephone will be included in the panel. Further, households without
internet access are provided computers and internet access. Thus the panel itself is
representative of 97% of the US population (http://www.knowledgenetworks.com/knpanel).
For this study, a randomly selected sample of 3689 adults aged ≥18 from the panel was
invited by KN to participate. Oversamples of African Americans and Hispanics (from KN’s
Latino Panel) were included to facilitate comparison by race/ethnicity. The survey was
fielded and administered as a web survey by KN in both English and Spanish. KN sends
emails and telephone reminders to study participants to maximize participation. 2079
respondents completed the survey for a 56% completion rate. To reduce any potential effects
of non-response and non-coverage biases among the study respondents, KN includes
weighting variables in the data file. These incorporate design-based weights to account for
the recruitment of the panelists and both panel-based and study-specific post-stratification
weights benchmarked against the most recent Current Population Survey (CPS) with respect
to demographic and geographic distributions of the US population aged ≥18 and for
Hispanic language usage from the 2006 Pew Hispanic Center Survey. The post-stratification
variables include gender, age, race/ethnicity, education, census region, metropolitan area,
internet access, and primary language used. Language usage adjustments allow for the
correct proportional fitting of Spanish-speaking members relative to other English-speaking
Hispanic and non-Hispanic panel members. More information on the KN research panel is
available from their website (http://www.knowledgenetworks.com/knpanel).
A note about the timing of our survey: though vaccine supply was unpredictable in fall,
2009, supply had stabilized by the time our survey was in the field (between January 22nd
and February 1st 2010). Our survey was fielded for 10 days at a time when vaccine had been
available in large quantities for weeks (Centers for Disease Control and Prevention, 2010b).
We did not collect information on the date of vaccination, however, and are unable to rule
out potential disequilibria caused by temporal changes in vaccine supply and communication
during fall, 2009.
Survey Instrument and Measures
The questionnaire focused on attitudes and beliefs towards the 2009 H1N1 virus (identified
interchangeably as swine flu) and acceptance of the H1N1 influenza vaccine, past vaccine
behavior, knowledge of membership in a priority group, and access to health insurance and
healthcare. KN collects demographic variables as part of their research procedures. We will
outline measures used in each level of the social ecological framework below.
Intrapersonal level
The intrapersonal level included measures about attitudes toward the virus and the H1N1
vaccine, past vaccine behavior, and perceived membership in a priority group for
vaccination. Three items measured perceived risk from the virus (see Table 3). An
Kumar et al. Page 4













exploratory factor analysis (principal factor extraction) indicated that the three items loaded
on a single factor (Cronbach’s alpha=0.83). Similarly, three other items measured perceived
risk from the vaccine itself. These three items also loaded on a single factor in a factor
analysis (Cronbach’s alpha=0.79). We thus created two scales: “Disease Risk Perception”
and “Vaccine Risk Perception” (Table 3). The vaccine risk perception items gauged beliefs
about vaccines in general but were flanked in the questionnaire by questions asking
specifically about swine flu and the H1N1 vaccine. Intuitively, people who believe that most
vaccines are not safe or that vaccines are riskier than the disease are expected to be less
willing to get the influenza vaccine. A mean score was calculated for each individual for
each scale. Higher values on each scale reflect increasing risk perception.
Other attitudinal measures included perceived effectiveness of vaccination: “How effective
do you think the following behaviors are in protecting you (or others) from swine flu?—
Getting the 2009 swine flu vaccine.” Responses were dichotomized by collapsing ‘not at all’
and ‘only a little effective’ (“Not Effective”), and ‘moderately’ and ‘very effective’
(“Effective”).
Perceived vaccine safety was measured using one item: “The newly developed vaccine for
swine flu is safe.” Responses were dichotomized by collapsing ‘strongly disagree’ and
‘disagree’ (“Disagree”), and ‘agree’ and ‘strongly agree’ (“Agree”). A scale for
measurement of trust in the government’s handling of the pandemic has been described
elsewhere (Quinn et al., 2009). The seven items in this scale loaded on a single factor with
Cronbach’s alpha=0.93, Mean=2.44 (Range 1–4), SD=0.69.
One item assessed history of seasonal flu vaccine acceptance (“annually” and “most years
but not all” collapsed into “Regularly;” “once or twice” and “never” collapsed into
“Seldom”).
Perceived membership in a priority group, i.e. “Subjective Priority” was measured using this
item, “Are you in a priority group to get the swine flu vaccine first?” (“No” and “Don’t
know” collapsed into “No”).
Interpersonal level
The interpersonal level included measures of social influence on vaccine behavior. The
number of people influencing a positive vaccination decision was assessed by asking, “Do
you think the following people want you to get the swine flu vaccine?—best friend,
sibling(s), parent(s), spouse or partner, and daughter or son.” The total number of positive
responses yielded a score ranging from 0–5, labeled “size of influential network.” Another
question gauged perceived social norm: “How many of your friends and family got the
swine flu vaccine?” (“Some,” “Most,” and “almost all” collapsed into “Most,” compared
with “Very few”).
Institutional level
The institutional level included the amount of information received and influence from the
healthcare provider. We assessed having a regular health care provider (yes/no) and the
amount of information received from the health care provider regarding swine flu (4–point
scale from ‘none at all’ to ‘a lot’). The response to “Do you think your doctor wants you to
get the swine flu vaccine?” was dichotomized as ‘No/Not Sure’ versus ‘Yes.’
Community Level
Disease presence and perceived risk at the community level were measured using five items
(Table 3). These items loaded on one factor (Cronbach’s alpha = 0.79). A mean score for the
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items was calculated for each individual with at least four responses (Table 3) for a scale
labeled “Community Risk.”
Policy Level
The policy level included a measure of access to health insurance (Do you have health
insurance? Yes/No). Membership in a priority group for vaccination, i.e. “Objective
Priority” was computed as a dichotomous variable based on the ACIP’s recommendations
(Centers for Disease Control and Prevention’s Advisory Committee on Immunization
Practices, 2009). We asked if respondents had been told by a health professional that they
had any of 9 chronic medical conditions. We gave those aged 25–64 years with a chronic
condition, pregnant women, respondents aged 18–24, and those who reported being
caretakers of children aged <6 months or healthcare/emergency medical services personnel a
score of 1; all others got a score of 0 (‘No’).
Outcome Variables
Two outcome variables were used: “Have you gotten the swine flu vaccine for yourself?”
(Yes/No) and “Do you intend to get the swine flu vaccination in the next month?” (Yes/No/
Don’t Know) (See Table 1). Those who reported “Don’t Know” were left out of analysis of
behavioral intent as the “Don’t Know” response is conceptually distinct from “No” or
“Yes;” our aim here is to compare the determinants of behavior, measured after the behavior
had been carried out, with the determinants of behavioral intent.
Data Analysis
The data were analyzed with STATA 11 (StataCorp, 2009) utilizing complex survey
analysis procedures (Lee, 2006). All analyses, with the exception of factor analyses and
reliability calculations, were weighted to be nationally representative. We carried out a total
of ten multiple binary logistic regression models. In five, we modeled H1N1 vaccine uptake
as the dependent variable. In the remainder, we modeled intent to get vaccinated “in the next
month” as the dependent variable. Each model included predictor variables measured at a
different level of the SEM with listwise deletion, and each is adjusted for the same set of
demographic covariates. Thus, we tested one model for each level of the social ecological
framework using Maximum Likelihood Estimation. We examined a histogram of Pearson
residuals, a quantile-normal plot of deviance, and box plots of leverage. We also compared
each model with and without bootstrapping (1000 replicates) to diagnose any violation of
assumptions of these logistic regression models (Efron & Tibshirani, 1994). The standard
error, p-value, and confidence intervals overlapped with and without bootstrapping, showing
that outliers and influential cases were not an issue. Therefore, we report the overall F-test
results for the models without bootstrapping for ease of interpretation. STATA reports a t-
test for each predictor in the logistic regression model with complex sampling instead of
Wald chi-square or z-test; a p-value ≤0.05 indicated a significant finding. In addition, a
McKelvey-Zavoina pseudo-R2 is reported for each logistic regression model (McKelvey &
Zavoina, 1975). Whereas there are many ways to calculate a pseudo-R2 value in a logistic
regression model, the McKelvey-Zavoina R2 provides a value that can be interpreted in a
way similar to the Ordinary Least Squares multiple regression R2. We conducted a bivariate
probit regression on H1N1 vaccine uptake and past vaccine uptake to test for correlation in
the error terms for the two outcomes. McNemar’s non-parametric test (McNemar, 1947) was
used to determine if there was a significant difference between under- and over-estimation
of membership in a priority group.
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Overall, 18.4% of respondents reported having received the H1N1 vaccine. 8.6% of those
who had not gotten the vaccine reported that they intended to get it ‘in the next month’
(Table 1). Table 2 shows demographic details by H1N1 vaccine uptake. Those who got the
vaccine were significantly older, and more likely to have health insurance and a regular
healthcare provider than those who did not get the vaccine. Minorities and lower educated
people were more likely to intend to get the vaccine in the next month.
Factors explaining vaccine uptake in each level of the SEM
We examined the significance of variables within each level of the social ecological
framework to explain vaccine uptake in simple and multiple binary logistic regression
models. Multiple logistic regression models to predict vaccine uptake by variables in each
level were controlled for demographic factors (income, education, age, gender, and race).
We present results from separate analyses for behavior (got the vaccine vs. did not get it)
and behavioral intent (intend to get the vaccine vs. do not intend to get it) for those who had
not yet received the vaccine. Given the cross-sectional nature of the data analyzed, we
present the latter analysis as a comparison to test whether variables—especially attitudinal
variables—that explain vaccine behavior (which was measured after the behavior had been
carried out) also explain behavioral intent. We first report results from a multiple binary
logistic model including only demographic variables, and follow that with models at each
level of the SEM, controlling for demographics.
Demographic factors correlated with vaccine uptake—Demographic factors,
including age, race/ethnicity, education, income, and gender were related to the dependent
variable, having gotten the 2009 H1N1 vaccine (F (11, 1988) = 2.26; p<0.01). This model
resulted in a McKelvey-Zavoina R2 of 0.06. Older participants (OR = 1.02 for each year)
were more likely to have gotten the vaccine adjusting for other demographics (income,
education, age, gender, and race) (p=0.001). Other demographic characteristics were not
related to having gotten the vaccine.
Minorities (Hispanics OR = 4.69; Blacks OR = 2.18) were more likely than Whites to intend
to get the vaccine when a similar demographics-only model was used to examine behavioral
intent. Those with high school education were less likely (OR = 0.46) to intend to get the
vaccine than those with less than a high school education. Other demographic factors were
not significantly related to intention to get vaccinated.
Intrapersonal level—We measured perceived risk from H1N1 using the ‘Disease Risk
Perception’ scale (Table 3). For a majority of respondents, perceived risk of getting the
disease, risk of complications from H1N1, and worry about getting very sick from H1N1
were only slightly or not at all important in their vaccine decision. We measured perceived
risk from the vaccine using the ‘Vaccine Risk Perception’ scale. Between 19% and 28%
reported agreement or strong agreement with statements about vaccines being unsafe or
riskier than the disease (Table 3).
In multiple binary logistic regression with H1N1 vaccine uptake as the outcome,
independent variables from the intrapersonal level—including attitudinal variables as well as
past acceptance of the vaccine—controlling for demographic factors (F (18, 1799) = 8.19;
p<0.001), resulted in a McKelvey-Zavoina R2 of 0.53. The odds of vaccine uptake increased
by 2.27 per unit increase on the ‘Disease Risk Perception’ scale. Those who perceived that
getting the 2009 H1N1 vaccine is an effective way to prevent illness had 3.25 times the odds
of others of having gotten the vaccine. Perceived risk from the vaccine predicted lower odds
of vaccine uptake even after adjustment (OR=0.57), and perceived safety of the vaccine was
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related to increased odds of vaccine acceptance (OR=3.29). Trust in the government’s
handling of the pandemic was a significant predictor of acceptance of the vaccine only
before adjustment. Subjective priority was related to greater odds of vaccine acceptance with
p = 0.06 (OR=1.74). Those with a history of ‘regular’ acceptance of seasonal flu vaccine
were 3.68 times more likely to have gotten the vaccine compared to those who ‘seldom’
received the seasonal flu vaccine. We did consider the possibility that past uptake of the
seasonal flu vaccine and H1N1 vaccine uptake may be highly correlated and may be
explained by common unobserved factors. In a bivariate probit model with past vaccine
uptake and 2009 H1N1 vaccine uptake as the dependent variables and intrapersonal level
variables as predictors, rho = 0.43; p<0.001, suggesting that the error terms in the equations
predicting the two dependent variables are correlated. This variable may capture the impact
of unobserved factors—such as propensity to accept vaccines—on H1N1 vaccine uptake.
Furthermore, in published studies examining influenza vaccine uptake, past vaccination has
been commonly used as a predictor. We therefore report results from a model including past
vaccine uptake as a predictor of H1N1 vaccination. Removing this variable from the
intrapersonal level model reduced the explained variance in vaccine uptake (McKelvey-
Zavoina R2) to 0.49.
Intent to get the vaccine was predicted by the same variables that predicted vaccine
behavior: Disease Risk Perception, perceived effectiveness and safety of the vaccine,
Vaccine Risk Perception, and getting the seasonal flu vaccine regularly predicted intention
to get the vaccine (Table 4). Subjective priority did not predict vaccination intention after
controlling for other variables within the intrapersonal level. Additionally, and similar to the
analysis of vaccine behavior, trust in the government predicted intention to get the vaccine
before, but not after, controlling for other intrapersonal variables. Since similar variables
were found to predict vaccine uptake and intent to accept vaccine, we suspect that
intrapersonal variables, and specifically attitudinal variables, determine vaccine acceptance
and not vice versa (i.e., attitudinal variables are not formulated or reformulated after the
acceptance of a vaccine).
Interpersonal level—The interpersonal level—the number of people influencing a
positive vaccination decision and the number of people perceived to have gotten the vaccine
—controlling for demographic factors (F (13, 1924) = 16.98; p<0.001), resulted in a
McKelvey-Zavoina R2 of 0.47. Considering that individuals are embedded in their social
networks, we examined the additional variance explained by the interpersonal level when it
is added to the intrapersonal level—this resulted in a McKelvey-Zavoina R2 of 0.64.
Each additional person or group of people positively influencing vaccine acceptance was
associated with 1.67 times greater odds of vaccine acceptance in multiple logistic regression
(Table 4). Compared to respondents who reported ‘very few’ of their friends/family having
gotten the vaccine, respondents who reported that ‘most’ got the vaccine had 8.31 times the
odds of vaccine acceptance.
The analysis of intent to get the swine flu vaccine showed that each additional person
positively influencing the vaccine decision was associated with 3.69 times greater odds of
intending to get the vaccine—an odds ratio higher than that seen with the analysis of
behavior. In contrast to behavior, however, respondents who reported that ‘most’ friends/
family got the vaccine were not significantly more likely to intend to get the vaccine
themselves compared to those who reported that ‘very few’ of their friends/family had
gotten the vaccine.
Institutional level—The institutional level—including the amount of information about
swine flu received from the healthcare provider and the belief that your doctor wants you to
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get the vaccine—controlling for demographic factors and presence of a healthcare provider
(F (16, 1901) = 7.57; p<0.001) resulted in a McKelvey-Zavoina R2 of 0.34. Adding the
interpersonal level and intrapersonal levels increased the R2 to 0.65. After controlling for
having a regular healthcare provider, increasing amounts of information about swine flu
received from the health care provider were related to increased odds of vaccine acceptance
—those who received ‘a lot’ of information from their provider had 4.43 times the odds of
having received the vaccine compared to those who received no information. Furthermore,
belief that your doctor wants you to get the swine flu vaccine increased odds of vaccine
uptake by 7.45 times.
Having received ‘a lot’ of information from the healthcare provider was also related to the
intention to get the vaccine, and belief that your doctor wants you to get the swine flu
vaccine resulted in 13.44 times higher odds of intending to get the vaccine (Table 4).
Community level—We measured perceived presence of disease at the community level
with our 5-item ‘Community Risk’ scale. Between 12.3 and 20.1% of respondents reported
that statements about the presence of illness, school closings, hospital overcrowding, and
about swine flu being a serious problem in their community were mostly or completely
accurate. 38.9% reported that people in their community were very worried about swine flu
(Table 3).
Each unit increase on the ‘Community Risk’ scale resulted in 1.61 times greater odds of
having gotten the vaccine (F (12, 1970) = 2.57; p=0.002) (Table 4). Controlling for
demographic factors, the community level resulted in a McKelvey-Zavoina R2 of 0.08,
increasing to 0.65 on adding the other levels.
Each unit increase on this scale was also related to a 1.66 times greater odds of intending to
get the vaccine, suggesting that presence of disease in the community impacted both vaccine
behavior as well as intention to get the vaccine in the next month.
Policy level—The policy level—including access to health insurance and membership in a
priority group for vaccination—controlling for demographic factors (F (13, 1966) = 2.45;
p=0.003), resulted in a McKelvey-Zavoina R2 of 0.08; this increased to 0.65 with all the
other levels. Access to health insurance did not predict vaccine uptake in the overall sample.
Objective priority, i.e. whether or not someone was in a priority group, measured objectively
based on ACIP’s recommendations, was a significant predictor of vaccine uptake even after
controlling for health insurance access and demographic factors (OR=1.68).
Given the timing of our survey, it is not surprising that objective priority group is not related
to an intention to get the vaccine ‘in the next month’: when our survey was fielded, the CDC
was urging everyone to get vaccinated.
Expecting that the number of uninsured is higher among minorities than among Whites, we
examined the factors related to vaccine uptake in the policy level after stratifying the sample
by race. The percentages of uninsured by race/ethnicity in our sample were: 16% among
Whites, 21.5% among African Americans, and 40% among Hispanics (p<0.001),
comparable to national estimates (Agency for Healthcare Quality and Research, 2008).
Whereas having health insurance was not a significant predictor of vaccine uptake among
Whites, African Americans with health insurance had 3.13 times the odds of African
Americans without insurance of having gotten the vaccine (95% CI=1.11–8.79; p=0.03).
The bivariate relationship between having insurance and vaccine uptake was significant
among African Americans (Adjusted Wald F (1, 1910) = 6.86; p=0.008) but not among
Whites (Adjusted Wald F (1,1915) = 1.15; p=0.284) or Hispanics (Adjusted Wald F
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(1,1931) = 2.60; p=0.107). After adjustment for demographic variables and objective
priority status, African Americans with insurance had 2.97 times the odds of those without
insurance of having gotten the vaccine (95% CI=0.92–9.62; p=0.07) compared to an
OR=1.03 (p=0.95) among Whites, and OR=1.39 (p=0.27) among Hispanics. The policy
level model, after controlling for demographic factors, resulted in an R2 of 0.26 for African
Americans compared with 0.08 for Whites and 0.12 for Hispanics.
Overall Social Ecological Model—It is not our intention to interpret each predictor in
the overall SEM due to possible multicollinearity/singularity problems. However, the overall
model fit can be interpreted without any bias. 65% of the variance associated with H1N1
vaccine acceptance can be explained with all the levels of the social ecological framework
and demographic variables (F (28, 1702) = 9.17; p<0.001).
Priority groups for vaccination
We measured membership in a priority group objectively (based on ACIP guidelines) and
subjectively (respondents’ perceived membership in a priority group to receive the vaccine
first). Objective priority (at the policy level) and subjective priority (at the intrapersonal
level) were each associated with vaccine uptake. To examine the interaction of these
variables, we studied the distribution of subjective priority given objective priority status. As
shown in Table 5, of 995 respondents who were not in an ACIP priority group, only seventy
(7%) believed that they were. On the other hand, of 1058 respondents determined to be in an
ACIP priority group based on objective measures, 730 (69%) did not believe they were in a
priority group. Thus, the odds of underestimation of membership in a priority group were
10.43 times (95% CI = 8.15–13.52) that for overestimation (p<0.001). Vaccine uptake was
highest among those who subjectively and objectively were in a priority group (35.6%;
Table 5).
Conclusion
We believe that this is the first comprehensive study of factors related to influenza vaccine
uptake and the first use of the SEM to examine this issue. We have shown that variables at
all levels of the SEM impact having gotten the vaccine. The intrapersonal, interpersonal, and
institutional levels have large effects on vaccine uptake, as evidenced by the proportion of
variance explained by these levels individually. The community and policy levels explain a
smaller proportion of the variance in vaccine uptake, but the proportion of variance
explained by the policy level among African Americans is larger than among Whites or
Hispanics. Table 6 presents the impact of each level on influenza vaccine uptake along with
references of interventions designed to target the respective level.
The idea that individuals are embedded within social networks, which are in turn embedded
within institutions and communities and impacted by policies is important and forms the
theoretical basis for the SEM. We have shown, using self-reported survey data, that people’s
decision about getting the influenza vaccine is based not only on perceptions of their own
individual risk, but also on the prevalence of vaccine uptake in their networks, their
perceptions of disease risk in their communities, as well as on whether they are encouraged
to get the vaccine by their healthcare providers and whether federal healthcare policies favor
their access to the vaccine. A further test of the SEM’s theoretical basis would involve data
collected at various levels and from entire networks of individuals and is the direction our
work points us in.
Furthermore, Burke et al. have pointed out that there may exist ‘reciprocal determinism’
between various levels of the SEM and the impacts on behavior may involve interactions
Kumar et al. Page 10













between levels over time (Burke, Joseph, Pasick, & Barker, 2009). For example, the amount
of information provided by a healthcare provider may have impacted vaccine-risk perception
and hence vaccine uptake. We have not focused on interactions between levels in this study
but that is an important future direction for research in this field. In the meantime, our
findings should encourage public health practitioners to design interventions to
simultaneously target multiple levels of the SEM in order to impact vaccine uptake.
While our study is the first to examine vaccine uptake through the lens of multiple SEM
levels, multiple studies have studied the impacts of interventions at single levels. Among
recent studies of interventions to increase vaccine uptake, multiple studies intervened at the
intrapersonal (Bourgeois, Simons, Olson, Brownstein, & Mandl, 2008; Coady et al., 2008;
Doratotaj, Macknin, & Worley, 2008; Kimura, Nguyen, Higa, Hurwitz, & Vugia, 2007;
Nowalk et al., 2010; Panda, Stiller, & Panda, 2010) and institutional levels (Chapman, Li,
Colby, & Yoon, 2010; Lin et al., 2010; Minor et al., 2010; Nace, Hoffman, Resnick, &
Handler, 2007; Nowalk et al., 2010; Nowalk et al., 2008; Weaver et al., 2007). Relatively
fewer studies targeted interpersonal (Coady et al., 2008; Nace et al., 2007) and policy levels
(Coady et al., 2008; Kimura et al., 2007), and we could not find any studies that aimed to
increase uptake by targeting perceived risk at the community level.
Health education interventions (aimed at the intrapersonal level) that also targeted another
level of the SEM (Coady et al., 2008; Kimura et al., 2007; Lin et al., 2010; Nowalk et al.,
2008) were more effective than those targeting only the intrapersonal level (Bourgeois et al.,
2008; Doratotaj et al., 2008). Similarly, in a systematic review of interventions to increase
uptake among health care personnel, Lam et al. report that interventions that used role
models or improved access to vaccines in addition to health education were more effective
than health education alone (Lam, Chambers, MacDougall, & McCarthy, 2010). Kimura et
al. showed that whereas health education on its own was not effective in increasing vaccine
uptake, it was when combined with the provision of free vaccines at a well-publicized
“vaccine day” (Kimura et al., 2007). Nace et al. implemented an intervention employing not
only posters and videos to educate health care workers about the importance of influenza
vaccination, but also promotion of the vaccine by the leadership in the organization (Nace et
al., 2007), pointing to the importance of the social network, role models, and the
interpersonal level. Thus, though the intrapersonal level explained a larger proportion of the
variance in vaccine uptake compared to other levels in our study, interventions targeting this
level have been found to be most effective in conjunction with the interpersonal,
institutional, or policy levels. Beliefs and attitudes, which are the target of most
interventions at the intrapersonal level, may be more amenable to change when targeted by a
known person from the social network—friends, family, colleagues, role models—rather
than using passive education materials. Our study supports this possibility by showing that
larger proportions of the total variance in vaccine uptake can be explained by the
intrapersonal level in conjunction with the interpersonal level.
Increased or simplified access to vaccines appears also to improve the effectiveness of
interventions targeting the intrapersonal level (Kimura et al., 2007; Lam et al., 2010). We
categorize this as a policy-level variable. The small proportion of the variance explained by
the policy level is most likely due to free provision of the vaccine by the federal government
which facilitated access to the H1N1 vaccine in the overall sample. Although federal
funding covered the costs of the H1N1 vaccine itself as well as of administration at public
health departments, mass vaccination clinics and through commercial community
vaccinators effectively removing the need for insurance (Centers for Disease Control and
Prevention, 2009), African Americans without insurance were less likely to have gotten the
vaccine than those with insurance. Perhaps uninsured African Americans were not as aware
as those with insurance that the H1N1 vaccine was available free of cost. It is possible that
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communication to this subgroup failed to address the lack of health insurance as a perceived
barrier to influenza vaccine uptake. Thus, once again, our study points to the importance of
effective interventions at multiple levels: communication targeting the intrapersonal level as
well as improved access to vaccines through policy. In the future, communication to African
Americans should clearly indicate whether insurance is needed to cover the costs of
vaccination, and where those without insurance can go to get the vaccine. In September
2010, some provisions of the Affordable Care Act went into effect, including free provisions
of influenza vaccinations (U.S. Department of Health & Human Services, 2010). This
provision is not only important to help ensure that African Americans and others without
insurance can receive influenza vaccinations but it is equally important that this access is
widely communicated to the public.
Vlahov et al. have suggested that interventions aimed at multiple levels are especially
important when targeting hard-to-reach populations including minorities (Vlahov, Coady,
Ompad, & Galea, 2007). Coady et al. found that education materials such as posters, flyers,
etc., interpersonal dialog between implementers of the intervention and community
members during community meetings, and the provision of vaccine in clinics and door-to-
door campaigns resulted in an increase in interest in getting the influenza vaccine even
among hard-to-reach populations (Coady et al., 2008). Nowalk et al. found that they could
increase influenza vaccine uptake in all race/ethnicities at an inner city clinic through
interventions that included patient reminders, standing orders for vaccination, and increasing
access to the vaccine through community-based clinics and free flu shots (Nowalk et al.,
2008). Similarly, our results point out the importance of real and perceived access to vaccine
as a determinant of uptake by minorities, especially African Americans. The policy level
appears, therefore, to be especially important in removing racial disparities in influenza
vaccine uptake.
Another policy-level variable—objective priority—was a predictor of having gotten the
vaccine. However, people greatly underestimated their membership in a priority group. This
same effect was also reported during the 2004 influenza vaccine shortage (Brewer &
Hallman, 2006), and was alleviated by provider-issued vaccination recommendation during
the pandemic (Maurer, Uscher-Pines, & Harris, 2010a). We have shown here that this
underestimation has an effect on vaccine uptake: only 15% of those who underestimated
their presence in a priority group were vaccinated compared to 35% of those who realized
that they were in a priority group. This will be even more important in the future since in
2010, the ACIP instituted a universal recommendation for the flu vaccine for all over 6
months of age (Fiore et al., 2010). The low awareness of priority group status found in this
study suggests the need for extensive communication efforts aimed at groups such as young
and middle aged adults, who were not targeted for seasonal influenza vaccination in the past.
It also places significant responsibility on healthcare providers, who must take an aggressive
stance in communicating the need for the vaccine to their patients. Therefore, the CDC and
groups such as the American Medical Association should produce materials to support
physicians in playing this critical role in communication.
The amount of information received from a health care provider about swine flu predicted
vaccine uptake. There may be a blurring of the distinction between the interpersonal and
institutional levels in the case of people who have a close relationship with their regular
healthcare provider. However, in the US, where care is provided through large physician
practices and interactions with physicians are typically of short duration, we believe we are
justified in categorizing the amount of information received from the healthcare provider as
an institutional level variable (Yarnall, Pollak, Ostbye, Krause, & Michener, 2003). There
may be other channels for receiving information about the disease, each of which may have
an influence on behavior (Maurer et al., 2010c). Furthermore, there may be interactions
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between the institutional and intrapersonal levels: Cummings et al. showed that exposure to
‘pro-swine flu shot information’ impacted perceived efficacy of vaccination (Cummings et
al., 1979). Such interactions are an avenue for future research.
We have shown that the interpersonal level is extremely important, explaining 47% of the
variance in vaccine behavior. In addition, the odds of intending to get the vaccine were even
higher than the odds of having gotten the vaccine for those with a larger ‘size of influential
network’ of family and friends who want them to get the vaccine. People who intend to get
the vaccine may have had the opportunity to discuss vaccine behavior with more people in
their network than those who already got the vaccine had a chance to do. Whether most
friends and family got the vaccine appears to impact vaccine behavior but not behavioral
intent. We hypothesize that people may have gone with their family to get the vaccine
during the second wave of the pandemic. However, those who intended to get the vaccine
after January may be part of a social network that weighed the pros and cons of the decision,
with fewer friends/family having already gotten the vaccine. Our results showing the
importance of social networks both in directly influencing individuals and in establishing
social norms should be incorporated into messages to convince individuals to get vaccinated.
For example, we suggest that older adults, over 65, who have a strong history of prior
vaccination, may be important messengers and role models in reaching out to younger
members of their familial and social networks. One example of this type of message is being
utilized in 2011 in the state of Maryland: in public service announcements, grandparents
advocate for influenza immunization for their grandchildren by talking directly to their adult
son/daughter.
In agreement with other studies (Maurer et al., 2010b; SteelFisher, Blendon, Bekheit, &
Lubell, 2010), we find that intrapersonal variables such as risk perception from the disease
and the vaccine are related to vaccine uptake—both having gotten the vaccine and intention
to get it. In addition, past vaccine uptake is strongly correlated with 2009 H1N1 vaccine
uptake. It is possible that these two behaviors are endogenous, however, and we caution
readers about the interpretation of this finding in our and previous studies (Eastwood et al.,
2010; Maurer et al., 2009; Schwarzinger et al., 2010; Seale et al., 2010). There may be
unobserved factors that impacted 2009 H1N1 vaccine uptake via past vaccination behavior.
A common critique of cross-sectional studies of vaccine uptake is that attitudinal variables
(such as belief in vaccine safety) found to be correlated with behavior could well be a result
of the behavior rather than the other way around. We have provided evidence that similar
attitudinal variables also impact intention to get the vaccine. This suggests that these
attitudes are indeed determinants of vaccine uptake. Overall, our estimate of vaccine uptake
is similar to that estimated by the CDC (Centers for Disease Control and Prevention, 2010c),
providing confidence that our sample accurately represents the US population.
Disease prevalence and perceived risk in the community impact behavior. Our ‘Community
Risk’ scale shows that we can measure perceived prevalence and risk of disease in the
community and that this social context impacts vaccine uptake. Another community-level
belief that may impact vaccine uptake is the number of people in the community that the
respondent perceives has received the vaccine. This has implications for perceived herd
immunity in the community, and should be examined in the future. Furthermore, availability
of vaccine in the community—which we would define as a policy variable and which we are
unable to estimate—may also determine vaccination rates (Centers for Disease Control and
Prevention, 2010d; Molly Hennessy-Fiske, 2010). Minorities were more likely than Whites
to intend to get the vaccine ‘in the next month.’ This may be because more minorities took
their time to arrive at a decision regarding getting the vaccine; on the other hand, minority
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communities may have found it more difficult than Whites to access the vaccine until after
the vaccine shortage had passed.
In sum, we have shown that attitudinal factors and past behavior at the intrapersonal level,
the beliefs and actions of others in the social environment at the interpersonal level,
information from a regular health care provider at the institutional level, presence of disease
and risk at the community level, and access to health care and membership in a priority
group at the policy level, all impact vaccine uptake. This work has clear implications for the
design of targeted communication through interpersonal channels to impact vaccine uptake
among at-risk people. The study also suggests that policy-level changes including increasing
access to health insurance as a result of health reforms in the US could influence vaccine
uptake in the future.
Importantly, this study validates the levels of the SEM as determinants of vaccine uptake
behavior. Additionally, the finding that each level explains a proportion of the variance
associated with the vaccine decision and all levels together explain more than any individual
level effectively expands the possible range of interventions to increase vaccination and
implores health practitioners to design interventions targeting multiple levels of the social
ecological framework in order to get the greatest increases in influenza vaccine uptake.
Future research could explicitly initiate formal tests of the SEM with data collected at
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Table 1
Distribution of vaccine decision in sample
Vaccine Decision Unweighted N Weighted %
Behavior (N=2059a)
 Got the vaccine 403 18.4
 Did not get the vaccine 1656 81.6
Behavioral Intent (N=1656)
 Intend to get the vaccine in the next month 151 8.6
 Do not intend to get the vaccine 1109 73.3
 Don’t Knowb 396 18.1
a
20 cases with missing outcome variable were discarded for this study.
b
The ‘Don’t Know’ response is conceptually distinct from ‘Yes’ or ‘No,’ and was left out of the analyses of behavioral intent in the rest of this
study
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Table 3
Scales to measure risk at the intrapersonal level (Disease Risk Perception and Vaccine Risk Perception), and
the community level (Community Risk).
Survey Question Na %b
Intrapersonal Level
Disease Risk Perception scale; α=0.83 1989c
How important is each of the following reasons in your decision about the swine flu vaccine?
I am at risk of getting swine flu 2012
 Not important at all 935 47.90
 Slightly important 493 26.56
 Moderately Important 345 17.48
 Very important 239 08.06
I am at risk of complications from the swine flu 2005
 Not important at all 942 48.00
 Slightly important 476 26.00
 Moderately Important 314 14.05
 Very important 273 11.94
I’m worried about getting very sick from swine flu 2019
 Not important at all 589 34.00
 Slightly important 487 25.82
 Moderately Important 385 18.82
 Very important 558 21.35
Vaccine Risk Perception scale; α =0.79 1972c
Indicate whether you agree or disagree with each of the following statements
A vaccine is riskier/more dangerous than the disease itself 2004
 Strongly disagree 420 21.14
 Disagree 982 51.63
 Agree 489 22.06
 Strongly agree 113 05.17
Most vaccines are not safe 2008
 Strongly disagree 426 21.96
 Disagree 1150 58.77
 Agree 348 15.51
 Strongly agree 84 03.77
Children are at greater risk from vaccines than from diseases 1995
 Strongly disagree 390 21.29
 Disagree 1031 50.32
 Agree 462 24.01
 Strongly agree 112 04.39
Community Level
Community Risk scale; α=0.79 2042d
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Survey Question Na %b
How accurate is each of the following statements in describing swine flu in your community?
There are lots of people in my community who have or have had swine flu 2039
 Completely Inaccurate 745 32.98
 Mostly Inaccurate 923 47.08
 Mostly accurate 331 18.62
 Completely accurate 40 01.32
Schools have been closed in my community as a result of swine flu 2044
 Completely Inaccurate 1,241 58.55
 Mostly Inaccurate 470 24.41
 Mostly accurate 227 11.64
 Completely accurate 106 05.40
Hospitals in my community have been overcrowded because of swine flu 2039
 Completely Inaccurate 1026 49.03
 Mostly Inaccurate 754 38.76
 Mostly accurate 198 09.89
 Completely accurate 61 02.32
People in my community are very worried about swine flu 2037
 Completely Inaccurate 433 18.02
 Mostly Inaccurate 831 43.55
 Mostly accurate 646 33.50
 Completely accurate 127 04.93
Swine flu is a serious problem in my community 2036
 Completely Inaccurate 806 40.29
 Mostly Inaccurate 915 46.99
 Mostly accurate 252 10.58
 Completely accurate 63 02.15
Scales Mean SD
Disease Risk Perception scale (Range 1–4) 2.12 0.95
Vaccine Risk Perception scale (Range 1–4) 2.11 0.66






Number of cases with no missing values;
d
Number of cases with <2 missing values
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Table 6
Variance in vaccine uptake decision explained by levels of the Social Ecological Framework; N=1790. Also
shown are interventions designed to target the levels.
R2 (this study) Interventions
Policy 0.08 Access to vaccine: Free vaccines and door-to-door vaccination1,3
Policy + Community + Institutional + Interpersonal
+ Intrapersonal 0.65
Community 0.08





; Choice of intranasal and
injection vaccines5,8; Standing orders for vaccination10
Institutional + Interpersonal + Intrapersonal 0.65
Interpersonal 0.47 In-person education2; Information provided at community
meetings3
Interpersonal + Intrapersonal 0.64




(Kimura et al., 2007);
2
(Nace et al., 2007);
3
(Coady et al., 2008);
4
(Doratotaj et al., 2008);
5
(Nowalk et al., 2010);
6
(Weaver et al., 2007);
7
(Panda et al., 2010);
8
(Lin et al., 2010);
9
(Bourgeois et al., 2008);
10
(Nowalk et al., 2008);
11
(Minor et al., 2010);
12
(Chapman et al., 2010)
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